A decade of hope begins for the treatment of acute myeloid leukemia thanks to new treatments like FLT3 inhibitors Published on 21/06/2021 New drugs, like FLT3 inhibitors, improve survival rates in people with acute myeloid leukemia, acting on altered intracellular signaling pathways that allow cancer cells to grow
MD Anderson Cancer Center Madrid – Hospiten presents its app for patients Published on 16/06/2021 The center’s new app allows patients to manage their medical appointments and see the results of their tests, among other functions
Fusion biopsy detects 30% more aggressive prostate cancers and improves diagnostic accuracy by 97% Published on 10/06/2021 The technique is a minimally invasive procedure that offers a highly accurate anatomical map of the prostate showing the areas affected by the tumor and allows planning of personalized treatment
Cancer surgery is safe during the pandemic and should not be postponed, according to a study conducted at MD Anderson Madrid – Hospiten Published on 03/06/2021 A study carried out by MD Anderson Cancer Center Madrid – Hospiten between March 16 and April 14, 2020, in the midst of the pandemic, analyzed 334 oncological surgeries, which had a complication rate similar to that of any pre-COVID-19 period
Electronic cigarettes should not be an alternative to tobacco because they generate more addiction and lead to serious health consequences Published on 27/05/2021 The long-term effects of this type of device on the health are unknown, but studies already show dysplasia (abnormal cells), severe lung disease, and even the need for lung transplants in extreme cases
The number of severe skin tumors has tripled since the beginning of the pandemic due to delayed diagnosis Published on 20/05/2021 Tumors that are usually treated by dermatologists and are generally caught early, have become more advanced tumors and are, therefore, more complex and expensive to treat
Llega el encuentro Mujerhoy Cancer Care 2021 sobre Salud, Cuidados y Prevención del Cáncer en la Mujer Published on 07/05/2021 El próximo 19 de mayo, de 16:00 a 18:00 horas, conéctate en directo a una nueva edición del evento sobre el cáncer en la mujer.
Patients with advanced ovarian cancer and a BRCA mutation achieve disease-free intervals of about 5 years thanks to treatment with PARP inhibitors Published on 06/05/2021 PARP inhibitors are a series of drugs that intervene in the repair of genetic damage, and it has been shown that, after surgery or chemotherapy, they achieve high remission rates in advanced ovarian cancer with disease-free survival rate of up to 56 months compared to the 13 months previously achieved.
Palliative surgery in peritoneal carcinomatosis can make a difference of months in the survival of the patient with improved quality of life Published on 29/04/2021 PIPAC, a palliative technique for intraperitoneal administration of chemotherapy, can increase the average survival rate by between 16 and 42 months in patients with peritoneal carcinomatosis
Prostatic radiosurgery can reduce the duration of conventional treatment from 4-7 weeks to 5 days Published on 14/04/2021 The technique is ideal for patients whose disease is confined to the prostate or is localized prostate cancer, who represent 85% of prostate tumor cases